hSSTR2 expression and octreotide treatment reverses multidrug resistance of BxPC-3 human pancreatic cancer cells

Oncology Reports

Volumn 22, Issue 6, 2009, Pages 1391-1396

  Sui, Chenguang ^a   Ma, Qingyong ^a   Nan, Kejun ^a   Xiao, Juxiang ^a   Suo, Aili ^a   Shad, Huanchen ^a   Zhao, Lei ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Lentivirus vector; Multidrug resistance; Octreotide; Pancreatic cancer; Somatostatin analogue

Indexed keywords

CISPLATIN; EPIRUBICIN; FLUOROURACIL; GEMCITABINE; LENTIVIRUS VECTOR; LUNG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; OCTREOTIDE; SOMATOSTATIN RECEPTOR 2;

ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CELL STRAIN BXPC 3; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIVITY; EXPRESSION VECTOR; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IC 50; MARKER GENE; MULTIDRUG RESISTANCE; PANCREAS CANCER; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CELL LINE; CELL LINE, TUMOR; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG RESISTANCE, MULTIPLE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITORY CONCENTRATION 50; LENTIVIRUS; OCTREOTIDE; PANCREATIC NEOPLASMS; RECEPTORS, SOMATOSTATIN; RNA, MESSENGER;

EID: 70449336314     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000579     Document Type: Article

References (26)

1. König J, Hartel M, Nies AT, Martignoni ME, Guo J, Büchler MW, Friess H and Keppler D: Expression and localization of human multidrug resistance protein (ABCC) family members in pancreatic carcinoma. Int J Cancer 115: 359-367, 2005.
2. Pollak MN and Schally AV: Mechanisms of antineoplastic action of somatostatin analogs. Proc Soc Exp Biol Med 217: 143-192, 1998.
3. Qin RY, Fang RL, Gupta MK, Liu ZR, Wang DY, Chang Q and Chen YB: Alteration of somatostatin receptor subtype 2 gene expression in pancreatic tumor angiogenesis. World J Gastroenterol 10: 132-135, 2004.
4. Portela-Gomes GM, Stridsberg M, Grimelius L, Oberg K and Janson ET: Expression of the five different somatostatin receptor subtypes in endocrine cells of the pancreas. Appl Immunohistochem Mol Morphol 8: 126-132, 2000.
5. Li M, Li W, Kim HJ, Yao Q, Chen C and Fisher WE: Characterization of somatostatin receptor expression in human pancreatic cancer using real-time RT-PCR. J Surg Res 119: 130-137, 2004.
6. Buscail L, Vernejoul F, Faure P, Torrisani J and Susini C: Regulation of cell proliferation by somatostatin. Ann Endocrinol (Paris) 63: 2S13-2S18, 2002.
7. Reubi JC, Horisberger U, Essed CE, Jeekel J, Klijn JG and Lamberts SW: Absence of somatostatin receptors in human exocrine pancreatic adenocarcinomas. Gastroenterology 95: 760-763, 1988.
8. Portela-Gomes GM, Stridsberg M, Grimelius L, Rorstad O and Janson ET: Differential expression of the five somatostatin receptor subtypes in human benign and malignant insulinomas - predominance of receptor subtype 4. Endocr Pathol 18: 79-85, 2007.
9. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM and Deeley RG: Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650-1654, 1992.
10. Scheffer GL, Wijngaard PL, Flens MJ, Izquierdo MA, Slovak ML, Pinedo HM, Meijer CJ, Clevers HC and Scheper RJ: The drug resistance-related protein LRP is the human major vault protein. Nat Med 1: 578-582, 1995.
11. Schadendorf D, Makki A, Stahr C, van Dyck A, Wanner R, Scheffer GL, Flens MJ, Scheper R and Henz BM: Membrane transport proteins associated with drug resistance expressed in human melanoma. Am J Pathol 147: 1545-1552, 1995.
12. Fisher WE, Doran TA, Muscarella P II, Boros LG, Ellison EC and Schirmer WJ: Expression of somatostatin receptor subtype 1-5 genes in human pancreatic cancer. J Natl Cancer Inst 90: 322-324, 1998.
13. Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative CT method. Nat Protoc 3: 1101-1108, 2008.
14. Noma B, Sasaki T, Fujimoto Y, Serikawa M, Kobayashi K, Inoue M, Itsuki H, Kamigaki M, Minami T and Chayama K: Expression of multidrug resistance-associated protein 2 is involved in chemotherapy resistance in human pancreatic cancer. Int J Oncol 33: 1187-1194, 2008.
15. Lee JU, Hosotani R, Wada M, Doi R, Koshiba T, Fujimoto K, Miyamoto Y, Tsuji S, Nakajima S, Hirohashi M, Uehara T, Arano Y, Fujii N and Imamura M: Antiproliferative activity induced by the somatostatin analogue,TT-232 in human pancreatic cancer cells. Eur J Cancer 38: 1526-1534, 2002.
16. Lopez F, Ferjoux G, Cordelier P, Saint-Laurent N, Estève JP, Vaysse N, Buscail L and Susini C: Neuronal nitric oxide synthase: a substrate for SHP-1 involved in sst2 somatostatin receptor growth inhibitory signaling. FASEB J 15: 2300-2302, 2001.
17. Lasfer M, Vadrot N, Schally AV, Nagy A, Halmos G, Pessayre D, Feldmann G and Reyl-Desmars FJ: Potent induction of apoptosis in human hepatoma cell lines by targeted cytotoxic somatostatin analogue AN-238. J Hepatol 42: 230-237, 2005.
18. Romani R and Morris DL: SMS 201.995 (Sandostatin) enhances in vitro effects of 5-fluorouracil in colorectal cancer. Eur J Surg Oncol 21: 27-32, 1995.
19. Diaconu CC, Szathmári M, Kéri G and Venetianer A: Apoptosis is induced in both drug-sensitive and multidrug-resistant hepatoma cell by somatostatin analogue TT-232. Br J Cancer 80: 1197-1203, 1999.
20. Fisher WE, Wu Y, Amaya F and Berger DH: Somatostatin receptor subtype 2 gene therapy inhibits pancreatic cancer in vitro. J Surg Res 105: 58-64, 2002.
21. Vernejoul F, Faure P, Benali N, Calise D, Tiraby G, Pradayrol L, Susini C and Buscail L: Antitumor effect of in vivo somatostatin receptor subtype 2 gene transfer in primary and metastatic pancreatic cancer models. Cancer Res 62: 6124-6131, 2002.
22. Du ZY, Qin RY, Xia W, Tian R and Kumar M: Gene transfer of somatostatin receptor type 2 by intratumoral injection inhibits established pancreatic carcinoma xenografts. World J Gastroenterol 11: 516-520, 2005.
23. Szereday Z, Schally AV, Szepeshazi K, Bajo AM, Hebert F, Halmos G and Nagy A: Effective treatment of H838 human non-small cell lung carcinoma with a targeted cytotoxic somatostatin analog, AN-238. Int J Oncol 22: 1141-1146, 2003.
24. Barnett P: Somatostatin and somatostatin receptor physiology. Endocrine 20: 255-264, 2003.
25. Benali N, Ferjoux G, Puente E, Buscail L and Susini C: Somatostatin receptors. Digestion 621: 27-32, 2000.
26. Celinski SA, Fisher WE, Amaya F, Wu YQ, Yao Q, Youker KA and Li M: Somatostatin receptor gene transfer inhibits established pancreatic cancer xenografts. J Surg Res 115: 41-47, 2003.